2024/01/12 | Grants & Awards | Surgical technologies
The ARTORG spinoff LEM Surgical has closed an oversubscribed series B round, raising CHF 22 million from new Swiss and US investors. The funds will propel the development of its robotic spinal cord surgery system and preparation for FDA submission.
Surgical robots can improve the quality of life for patients with spinal cord injury, but current technology still has limitations. The startup LEM Surgical is developing a next-generation robotic surgery platform, with its current focus dialled on the development and commercialisation of Sapien, its first robotic system for spine surgery.
The company was established in mid-2021 by Prof. Dr. Stefan Weber (CEO, CAScination AG & Head Image Guided Therapy ARTORG), Marco Matulic (CTO, CAScination AG), Simon Michel (CEO, Ypsomed Group), Prof. Dr. Andreas Raabe (Director, Department of Neurosurgery, Inselspital Bern) and Yossi Bar (previously Director R&D at Mazor Robotics Ltd).
With the proceeds from the oversubscribed series B round of CHF 22 million, LEM Surgical is well-positioned to advance its product development initiatives and readiness for FDA submission in the second half of 2024, to achieve its objectives and to solidify its potential in the field of surgical robotics.
News Startup Ticker, 5 January 2024